FDA NDC Directory · JSON-LD · Markdown

neostigmine methylsulfate

NDC 71288-501 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerMeitheal Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212804
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNEOSTIGMINE METHYLSULFATE (1.02 mg/mL)
Marketing started20210405
Package count1

External sources

Source: openFDA. Public-domain (CC0).